InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Abrahmsen Lars B., Vice-Président Senior. Insider active across 1 companies, notably Aprea Therapeutics, Inc.. Cumulatively, 5 reports have been published. The latest transaction was filed on 10 March 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
024,700 shares0
Common Stock
SEC:0001104659-22-033389:0·
€39,74350,000 shares@ €0.79490.67% mcap33.5% of flow
Common Stock
SEC:0001104659-21-123186·
€39,74350,000 shares@ €0.79490.67% mcap33.5% of flow
Common Stock
SEC:0001104659-21-123186:0·
€19,60825,000 shares@ €0.784333.0% of flow
Common Stock
SEC:0001104659-21-118360·
€19,60825,000 shares@ €0.78430.33% mcap16.5% of flow
Common Stock
SEC:0001104659-21-118360:0·
5 of 5 declarations
About Abrahmsen Lars B.
Lars B. Abrahmsen is the Senior Vice President and Chief Scientific Officer of Aprea Therapeutics, Inc. In this role, he leads the company's research and development initiatives. With deep expertise in the life sciences field, he is responsible for innovation and the development of new therapies. His leadership is essential in ensuring that Aprea's products meet the highest standards of safety and efficacy.
